Related Experiment Video
Updated: Jul 5, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Nicotine abstinence-induced cerebral blood flow changes by genotype
Ze Wang1, Riju Ray, Myles Faith
1Center for Functional Neuroimaging, Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, United States. zewang@mail.med.upenn.edu
Certain gene variants influence brain blood flow changes during nicotine abstinence, potentially explaining individual differences in nicotine dependence. This research identifies specific genetic markers linked to altered cerebral blood flow in smokers.
Area of Science:
- Neuroscience
- Genetics
- Addiction Research
Background:
- Nicotine dependence is a complex trait influenced by genetic factors.
- Previous research has identified genetic variants associated with nicotine dependence.
- Understanding the neural mechanisms linking genetics to nicotine dependence is crucial.
Purpose of the Study:
- To investigate the association between functional genetic variants and regional cerebral blood flow (rCBF) changes during nicotine abstinence versus satiety.
- To explore potential neural pathways through which genetic variations may contribute to nicotine dependence.
Main Methods:
- Utilized arterial spin labeled (ASL) perfusion MRI to measure rCBF in thirteen smokers.
- Scanned participants during nicotine abstinence (>12h) and satiety (smoking as usual).
- Genotyped participants for variants in dopamine D2 receptor (DRD2), COMT, and mu opioid receptor (OPRM1) genes.
Main Results:
- Carriers of DRD2-141 DelC variant and the COMT val/val genotype showed greater rCBF increases in craving-related regions during abstinence.
- Smokers with DRD2 C957T TT genotype exhibited less rCBF change compared to CC/CT genotypes.
- OPRM1 AA genotype was associated with significant rCBF increases in craving-related areas.
Conclusions:
- These findings suggest a neural mechanism linking specific genetic variants to nicotine dependence.
- The results highlight potential biological vulnerabilities in subgroups of smokers based on their genetic profiles.
- Further research can explore these genetic influences on brain function in addiction.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
